Susan Altschuller

Chief Financial Officer, ImmunoGen Inc.

Companies

Climb Bio, Inc.Chief financial officer Oct 1, 2025 to now¹
Mural Oncology plcBoard member Nov 7, 2023 to now²
Cerevel Therapeutics Holdings, Inc.Chief financial officer May 19, 2023 to Aug 5, 2024³
ImmunoGen Inc.Chief financial officer Jul 22, 2020 to Dec 27, 2022⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARClimb Bio, Inc., Chief financial officer
2
SEC EDGARMural Oncology plc, Board member
3
SEC EDGARCerevel Therapeutics Holdings, Inc., Chief financial officer
4
SEC EDGARImmunoGen Inc., Chief financial officer